Dr. John Farley on not using ivermectin to prevent or treat COVID | COVID-19 Update for Sep. 9, 2021

A discussion with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA, about what physicians and patients really need to know about ivermectin.

For more information on FDA approved clinical trials, visit: https://clinicaltrials.gov/  

0:00 AMA COVID-19 Update for September 9, 2021
0:36 What has the FDA identified thus far regarding the use of ivermectin products to treat COVID-19?
1:31 What are the dangers of taking a drug that is intended for use in animals?
2:15 What are the differences between ivermectin for veterinary purposes, verses when approved for human use (e.g., dosage, inactive ingredients)?
2:45 Why is it so important for physicians to actively manage ivermectin use in patients?
3:37 What are some of the biggest concerns about patients taking ivermectin—specifically to prevent COVID?
5:01 What about the usage of ivermectin to treat COVID?
6:39 How does a phenomenon like this happen (i.e., hype around using a drug that has no data to support it as a viable treatment against the virus)?

8:04 What’s your advice to physicians who have patients asking for and/or about the use of ivermectin?
Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.